Cargando…
Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
The exponential expansion of genomic data coupled with the lack of appropriate clinical categorization of the variants is posing a major challenge to conventional medications for many common and rare diseases. To narrow this gap and achieve the goals of personalized medicine, a collaborative effort...
Autores principales: | Hindi, Nagham N., Alenbawi, Jamil, Nemer, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468752/ https://www.ncbi.nlm.nih.gov/pubmed/34575654 http://dx.doi.org/10.3390/jpm11090877 |
Ejemplares similares
-
Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011) -
Assessing the genetic burden of familial hypercholesterolemia in a large middle eastern biobank
por: Gandhi, Geethanjali Devadoss, et al.
Publicado: (2022) -
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
por: Kamar, Amina, et al.
Publicado: (2021) -
GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
por: Kim, Hyoeun, et al.
Publicado: (2020) -
An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)